医学
多西紫杉醇
前列腺癌
荟萃分析
肿瘤科
雄激素剥夺疗法
内科学
随机对照试验
恩扎鲁胺
癌症
雄激素受体
作者
Soumyajit Roy,Gagan Fervaha,Daniel E. Spratt,Yilun Sun,Amar U. Kishan,Andrew Loblaw,Shawn Malone,Michael Ong,Fred Saad,Christopher J.D. Wallis,Scott C. Morgan
标识
DOI:10.1016/j.eururo.2024.03.018
摘要
There was some evidence that SOC plus ARPI plus RT reduced mortality compared with the next best strategy of SOC plus ARPI in patients with low-volume de novo mHSPC. A meta-analysis with individual patient data or an RCT is needed to confirm these findings.
科研通智能强力驱动
Strongly Powered by AbleSci AI